RAPT Therapeutics, Inc. (RAPT) Ownership

$1.72

north_east
$0.05 (2.99%)
Day's range
$1.6
Day's range
$1.73

RAPT Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 01/23/2025 22.35 M $35.32 M   100.00% 57.46%
ORBIMED ADVISORS LLC 02/14/2025 13.14 M $20.75 M   100.00% 33.76%
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 13.14 M $19.75 M   100.00% 33.76%
FORESITE CAPITAL MANAGEMENT VI LLC 02/14/2025 12.50 M $19.75 M   100.00% 32.13%
RTW INVESTMENTS, LP 02/14/2025 11.76 M $18.59 M   100.00% 30.24%
BVF INC/IL 02/14/2025 9.24 M $14.60 M   100.00% 23.74%
REDMILE GROUP, LLC 02/14/2025 6.48 M $10.23 M   1,183.43% 16.64%
DEEP TRACK CAPITAL, LP 02/14/2025 6.01 M $9.50 M   100.00% 15.45%
PERCEPTIVE ADVISORS LLC 02/14/2025 5.88 M $9.29 M   100.00% 15.11%
FMR LLC 02/13/2025 5.23 M $8.27 M   -0.05% 13.45%
VANGUARD GROUP INC 02/11/2025 2.94 M $4.65 M   -6.80% 7.56%
BLACKROCK FUNDING, INC. /DE 02/07/2025 2.30 M $3.63 M   -8.00% 5.91%
COLUMN GROUP LLC 02/14/2025 1.33 M $2.10 M   -50.44% 3.42%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 1.24 M $1.96 M   100.00% 3.20%
ADAR1 CAPITAL MANAGEMENT, LLC 02/13/2025 1.17 M $1.86 M   15,557.51% 3.02%
AFFINITY ASSET ADVISORS, LLC 02/13/2025 1.00 M $1.58 M   100.00% 2.57%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 862,886 $1.36 M   2.46% 2.22%
FEDERATED HERMES, INC. 02/13/2025 802,618 $1.27 M   0.33% 2.06%
D. E. SHAW & CO., INC. 02/14/2025 770,013 $1.22 M   -26.54% 1.98%
MILLENNIUM MANAGEMENT LLC 02/14/2025 737,704 $1.17 M   -23.15% 1.90%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 716,937 $1.13 M   4.94% 1.84%
EUCLIDEAN CAPITAL LLC 02/14/2025 657,899 $1.04 M   0.00% 1.69%
KINGDON CAPITAL MANAGEMENT, L.L.C. 02/14/2025 575,000 $908,500   -66.67% 1.48%
TWO SIGMA ADVISERS, LP 02/14/2025 503,700 $795,846   -28.55% 1.29%
GOLDMAN SACHS GROUP INC 02/11/2025 486,948 $769,378   22.42% 1.25%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 369,736 $584,183   25.50% 0.95%
DEUTSCHE BANK AG\ 02/14/2025 276,170 $436,349   -3.25% 0.71%
LOS ANGELES CAPITAL MANAGEMENT LLC 02/04/2025 219,997 $347,595   9.21% 0.57%
JPMORGAN CHASE & CO 02/12/2025 205,164 $324,158   1,128.31% 0.53%
CORMORANT ASSET MANAGEMENT, LP 02/14/2025 200,000 $316,000   -59.74% 0.51%
TWO SIGMA INVESTMENTS, LP 02/14/2025 180,465 $285,135   -65.32% 0.46%
UBS GROUP AG 02/14/2025 149,669 $236,477   418.86% 0.38%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 148,823 $235,233   -41.42% 0.38%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 125,000 $197,500   66.67% 0.32%
CAPTION MANAGEMENT, LLC 02/14/2025 125,000 $197,500   100.00% 0.32%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 116,925 $184,741   50.47% 0.30%
BANK OF NEW YORK MELLON CORP 02/04/2025 90,144 $142,428   -0.07% 0.23%
EXCHANGE TRADED CONCEPTS, LLC 01/21/2025 89,076 $140,740   0.00% 0.23%
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 02/14/2025 73,383 $115,945   100.00% 0.19%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 70,979 $112,147   0.05% 0.18%
HAP TRADING, LLC 02/13/2025 62,500 $26,563   100.00% 0.16%
CALLAN FAMILY OFFICE, LLC 02/07/2025 58,040 $91,703   100.00% 0.15%
SHAY CAPITAL LLC 02/14/2025 51,300 $81,054   100.00% 0.13%
ALLIANCEBERNSTEIN L.P. 02/12/2025 50,710 $80,122   0.00% 0.13%
GROUP ONE TRADING, L.P. 02/14/2025 49,011 $77,437   344.34% 0.13%
ALGERT GLOBAL LLC 02/14/2025 47,483 $75,000   0.00% 0.12%
HENNION & WALSH ASSET MANAGEMENT, INC. 01/15/2025 47,053 $74,344   -1.82% 0.12%
RHUMBLINE ADVISERS 01/30/2025 46,193 $72,975   0.00% 0.12%
JASPER RIDGE PARTNERS, L.P. 02/14/2025 45,650 $72,127   0.00% 0.12%
BARCLAYS PLC 02/13/2025 45,203 $71,000   13.78% 0.12%

RAPT Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 132 institutional investors and hedge funds held shares of RAPT Therapeutics, Inc.. The most heavily invested institutionals were:

Medicxi Ventures Management (Jersey) Ltd: 22.35 M

ORBIMED ADVISORS LLC: 13.14 M

TCG Crossover Management, LLC: 13.14 M

Foresite Capital Management VI LLC: 12.5 M

RTW INVESTMENTS, LP: 11.76 M

BVF INC/IL: 9.24 M

325.91% of RAPT Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 136.78 M shares in the last 24 months. This purchase volume represents approximately $235.26 M in transactions.